Mail

Australia markets closed

ALL ORDS
7,270.00
+3.40(+0.05%)
ASX 200
7,068.80
+3.60(+0.05%)
AUD/USD
0.6443
+0.0026(+0.40%)
OIL
90.33
+0.70(+0.78%)
GOLD
1,944.90
+5.30(+0.27%)
Bitcoin AUD
41,259.05
+35.07(+0.09%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Jasper Therapeutics, Inc. (JSPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

0.7800

+0.0288

(+3.83%)

At close: 04:00PM EDT

0.7790

-0.00

(-0.13%)

After hours:

07:19PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	83.23M
Enterprise value	-29.34M
Trailing P/E	0.53
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	0.75
Enterprise value/revenue	N/A
Enterprise value/EBITDA	0.51

Trading information

Stock price history

Beta (5Y monthly)	1.91
52-week change ³	-7.28%
S&P500 52-week change ³	17.24%
52-week high ³	3.8000
52-week low ³	0.3860
50-day moving average ³	1.2587
200-day moving average ³	1.4502

Share statistics

Avg vol (3-month) ³	311.25k
Avg vol (10-day) ³	605.78k
Shares outstanding ⁵	110.8M
Implied shares outstanding ⁶	110.8M
Float ⁸	57.27M
% held by insiders ¹	7.91%
% held by institutions ¹	87.68%
Shares short (30 Aug 2023) ⁴	1.09M
Short ratio (30 Aug 2023) ⁴	6.83
Short % of float (30 Aug 2023) ⁴	1.10%
Short % of shares outstanding (30 Aug 2023) ⁴	0.98%
Shares short (prior month 30 July 2023) ⁴	1.01M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2022
Most-recent quarter (mrq)	29 June 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-37.42%
Return on equity (ttm)	-65.58%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-57.14M
Net income avi to common (ttm)	-55.41M
Diluted EPS (ttm)	-0.9500
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	115.81M
Total cash per share (mrq)	1.04
Total debt (mrq)	3.23M
Total debt/equity (mrq)	2.93%
Current ratio (mrq)	13.22
Book value per share (mrq)	1.00

Cash flow statement

Operating cash flow (ttm)	-45.9M
Levered free cash flow (ttm)	-28.8M